Market Tracker

02/24 12:19pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

2.23
BATS BZX Real-Time Price
As of 12:18pm ET
 -0.015 / -0.67%
Today’s Change
1.93
Today|||52-Week Range
3.84
+4.95%
Year-to-Date
Argos Plummets 72%, Leads Biotech Movers
Feb 22 / TheStreet.com - Paid Partner Content
8 High-Yield Stocks With Falling Prices
Feb 21 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close2.24
Today’s open2.23
Day’s range2.19 - 2.24
Volume17,950
Average volume (3 months)2,349,202
Market cap$370.8M
Dividend yield--
Data as of 12:18pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-74.34%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.01%
P/E ratio2.1
Price/Sales0.99
Price/Book0.52

Competitors

 Today’s
change
Today’s
% change
MCRBSeres Therapeutics I...-0.11-1.20%
MRUSMerus NV+0.11+0.46%
BTXBioTime Inc0.000.00%
NVAXNovavax Inc+0.02+1.45%
Data as of 12:18pm ET, 02/24/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)$0.09
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts